Status: Recruiting
A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
Evaluate the safety and pharmacodynamics of multiple doses of ARCT-810 in adolescent and adult participants with OTC deficiency.
Participants needed: 9
Trial details
Phase: Phase 2Age: 12+Biological sex: AllType: InterventionalSponsor: Arcturus Therapeutics, Inc.Updated: Mar 17, 2025Locations: 1
Eligibility criteria
Willingness and ability to comply with all the protocol requirements, complete a... [+6]
Uncontrolled hypertension. [+19]